Literature DB >> 20007303

Breast, colorectal, and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition-Norfolk in relation to phytoestrogen intake derived from an improved database.

Heather A Ward1, Gunter G C Kuhnle, Angela A Mulligan, Marleen A H Lentjes, Robert N Luben, Kay-Tee Khaw.   

Abstract

BACKGROUND: The characterization of phytoestrogen intake and cancer risk has been hindered by the absence of accurate dietary phytoestrogen values.
OBJECTIVE: We examined the risk of breast, colorectal, and prostate cancers relative to phytoestrogen intake on the basis of a comprehensive database.
DESIGN: Demographic and anthropometric characteristics, a medical history, and 7-d records of diet were collected prospectively from participants (aged 40-79 y) in the European Prospective Investigation into Cancer and Nutrition-Norfolk (EPIC-Norfolk). Five hundred nine food items were analyzed by liquid chromatography-mass spectrometry/mass spectrometry, and (13)C(3)-labeled internal standards were analyzed for isoflavones (genistein, daidzein, glycitein, biochanin A, and formononetin), lignans (secoisolariciresinol and matairesinol), and enterolignans from gut microbial metabolism in animal food sources (equol and enterolactone). From the direct analysis, values for 10,708 foods were calculated. Odds ratios (ORs) for breast (244 cases, 941 controls), colorectal (221 cases, 886 controls), and prostate (204 cases, 812 controls) cancers were calculated relative to phytoestrogen intake.
RESULTS: Phytoestrogen intake was not associated with breast cancer among women or colorectal cancer among men. Among women, colorectal cancer risk was inversely associated with enterolactone (OR: 0.33; 95% CI: 0.14, 0.74) and total enterolignans (OR: 0.32; 95% CI: 0.13, 0.79), with a positive trend detected for secoisolariciresinol (OR: 1.60; 95% CI: 0.96, 2.69). A positive trend between enterolignan intake and prostate cancer risk (OR: 1.27; 95% CI: 0.97, 1.66) was attenuated after adjustment for dairy intake (OR: 1.19; 95% CI: 0.77, 1.82).
CONCLUSION: Dietary phytoestrogens may contribute to the risk of colorectal cancer among women and prostate cancer among men.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20007303     DOI: 10.3945/ajcn.2009.28282

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  37 in total

Review 1.  Anticancer and antimetastatic potential of enterolactone: Clinical, preclinical and mechanistic perspectives.

Authors:  Aniket V Mali; Subhash B Padhye; Shrikant Anant; Mahabaleshwar V Hegde; Shivajirao S Kadam
Journal:  Eur J Pharmacol       Date:  2019-02-14       Impact factor: 4.432

2.  High concentrations of a urinary biomarker of polyphenol intake are associated with decreased mortality in older adults.

Authors:  Raul Zamora-Ros; Montserrat Rabassa; Antonio Cherubini; Mireia Urpí-Sardà; Stefania Bandinelli; Luigi Ferrucci; Cristina Andres-Lacueva
Journal:  J Nutr       Date:  2013-06-26       Impact factor: 4.798

3.  Dietary lignan and proanthocyanidin consumption and colorectal adenoma recurrence in the Polyp Prevention Trial.

Authors:  Gerd Bobe; Gwen Murphy; Paul S Albert; Leah B Sansbury; Elaine Lanza; Arthur Schatzkin; Amanda J Cross
Journal:  Int J Cancer       Date:  2011-08-01       Impact factor: 7.396

Review 4.  Toxic phytochemicals and their potential risks for human cancer.

Authors:  Ann M Bode; Zigang Dong
Journal:  Cancer Prev Res (Phila)       Date:  2014-10-27

5.  Equol inhibits proliferation of human gastric carcinoma cells via modulating Akt pathway.

Authors:  Zhi-Ping Yang; Yan Zhao; Fang Huang; Jie Chen; Ya-Hong Yao; Jun Li; Xiao-Nan Wu
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

6.  Dietary intake of total polyphenol and polyphenol classes and the risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.

Authors:  Raul Zamora-Ros; Valerie Cayssials; Mazda Jenab; Joseph A Rothwell; Veronika Fedirko; Krasimira Aleksandrova; Anne Tjønneland; Cecilie Kyrø; Kim Overvad; Marie-Christine Boutron-Ruault; Franck Carbonnel; Yahya Mahamat-Saleh; Rudolf Kaaks; Tilman Kühn; Heiner Boeing; Antonia Trichopoulou; Elissavet Valanou; Effie Vasilopoulou; Giovanna Masala; Valeria Pala; Salvatore Panico; Rosario Tumino; Fulvio Ricceri; Elisabete Weiderpass; Marko Lukic; Torkjel M Sandanger; Cristina Lasheras; Antonio Agudo; Maria-Jose Sánchez; Pilar Amiano; Carmen Navarro; Eva Ardanaz; Emily Sonestedt; Bodil Ohlsson; Lena Maria Nilsson; Martin Rutegård; Bas Bueno-de-Mesquita; Petra H Peeters; Kay-Thee Khaw; Nicholas J Wareham; Kathryn Bradbury; Heinz Freisling; Isabelle Romieu; Amanda J Cross; Paolo Vineis; Augustin Scalbert
Journal:  Eur J Epidemiol       Date:  2018-05-15       Impact factor: 8.082

7.  Relationship of serum levels and dietary intake of isoflavone, and the novel bacterium Slackia sp. strain NATTS with the risk of prostate cancer: a case-control study among Japanese men.

Authors:  Yoshie Nagata; Yukiko Sugiyama; Fumimasa Fukuta; Akio Takayanagi; Naoya Masumori; Taiji Tsukamoto; Hiroshi Akasaka; Hirofumi Ohnishi; Shigeyuki Saitoh; Tetsuji Miura; Kaoru Moriyama; Hirokazu Tsuji; Hideyuki Akaza; Mitsuru Mori
Journal:  Int Urol Nephrol       Date:  2016-06-04       Impact factor: 2.370

Review 8.  O-desmethylangolensin: the importance of equol's lesser known cousin to human health.

Authors:  Cara L Frankenfeld
Journal:  Adv Nutr       Date:  2011-06-28       Impact factor: 8.701

Review 9.  Dietary flavonoid intake and risk of stomach and colorectal cancer.

Authors:  Hae Dong Woo; Jeongseon Kim
Journal:  World J Gastroenterol       Date:  2013-02-21       Impact factor: 5.742

10.  Hypospadias and maternal intake of phytoestrogens.

Authors:  Suzan L Carmichael; Mary E Cogswell; Chen Ma; Amparo Gonzalez-Feliciano; Richard S Olney; Adolfo Correa; Gary M Shaw
Journal:  Am J Epidemiol       Date:  2013-06-09       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.